Pathogenesis and therapy of gastric and duodenal ulcer disease (Q28194550)

Medical Clinics of North America

Europe PubMed Central

title

Pathogenesis and therapy of gastric and duodenal ulcer disease (English)

0 references

1 reference

2

David Y Graham

0 references

Akiko Shiotani

series ordinal

1

object named as

Akiko Shiotani

0 references

language of work or name

English

0 references

publication date

November 2002

0 references

published in

0 references

volume

86

0 references

issue

6

0 references

page(s)

1447-66, viii

0 references

cites work

Epidemiological study of peptic ulcer disease among Japanese and Koreans in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Mucosal changes in gastric ulceration and their response to carbenoxolone sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

The role of internal urease in acid resistance of Helicobacter pylori.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Acid-dependent adherence of Helicobacter pylori urease to diverse polysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Defective Inhibition of Gastrin Release by Antral Distension in Duodenal Ulcer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

pH dependence of acid secretion and gastrin release in normal and ulcer subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Pathogenesis of duodenal ulcer disease: the rest of the story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Perturbations in gastric physiology in Helicobacter pylori duodenal ulcer: are they all epiphenomena?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

A reliable method for the simultaneous identification of H pylori and gastric metaplasia in the duodenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Gastric metaplasia and Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

H. pylori in the pathogenesis of duodenal ulcer: interaction between duodenal acid load, bile, and H. pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

The physiology of gastric acid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Involvement of nitric oxide and prostaglandins in gastroprotection induced by bacterial lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Inhibition of gastric mucin synthesis by Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Does Helicobacter pylori affect gastric mucin expression? Relationship between gastric antral mucin expression and H. pylori colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Relation of H pyroli to gastric mucins and gastric surface mucous gel layer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Are genetic influences on peptic ulcer dependent or independent of genetic influences for Helicobacter pylori infection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Isolation of Helicobacter pylori from human faeces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Isolation of Helicobacter pylori from vomitus in children and its implication in gastro-oral transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Fecal and oral shedding of Helicobacter pylori from healthy infected adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Helicobacter pylori infection and the use of NSAIDs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Physical activity at work and duodenal ulcer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Stress and peptic ulcer: life beyond Helicobacter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Healing of benign gastric ulcer: comparison of cimetidine and placebo in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Evaluating gastric ulcer healing by endoscopic ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Campylobacter pylori detected noninvasively by the 13C-urea breath test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Accurate diagnosis of Helicobacter pylori. 13C-urea breath test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Rapid detection of anti-Helicobacter pylori IgG in urine using immunochromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Clinical usefulness of urine-based enzyme-linked immunosorbent assay for detection of antibody to Helicobacter pylori: a collaborative study in nine medical institutions in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

A new rapid test for detecting anti-Helicobacter pylori antibody excreted into urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Peptic ulceration in patients with chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Gastric and duodenal ulcer and their associated diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Duodenal pH in cystic fibrosis and its relationship to fat malabsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Role of maintenance sucralfate in prevention of duodenal ulcer recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Ranitidine 150 mg at night in the prevention of gastric ulcer relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Antimicrobial therapy of peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

The national ASGE survey on upper gastrointestinal bleeding. III. Endoscopy in upper gastrointestinal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

A comparison of omeprazole and placebo for bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Laparoscopic closure of perforated duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Laparoscopic and open operation in patients with perforated peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

Campylobacter pylori and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical efficacy of pantoprazole compared with ranitidine

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900083-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(02)00083-4

1 reference

Consolidated OpenCitations Corpus – April 2017

673303

673303

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference